by SD-AbarceoPharma | May 23, 2025 | Diabetes, News & Press releases, VDAC1
We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
Recent Comments